The Valley Desk

NCT02649790 · Interventional trial

Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications

Overall registry status Completed

Phase 1 · Phase 2

Conditions Acute Myeloid Leukemia (AML), Higher-Risk Myelodysplastic Syndrome (HR-MDS), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Colorectal Cancer (mCRC), Newly Diagnosed Intermediate/High-Risk MDS, Relapsed/Refractory Multiple Myeloma (RRMM)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov